ACHIEVE LIFE SCIENCES, INC. Insider Trading for March 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACHIEVE LIFE SCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACHIEVE LIFE SCIENCES, INC. for March 2016.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.85 | 135,000 | 114,750 | 135,000 | |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 4,688 | 0 | 14,062 | |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 3,125 | 0 | 6,250 | |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 2,500 | 0 | 2,500 | |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 1,875 | 0 | 0 | |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Sell | S | 0.83 | 3,254 | 2,701 | 73,853 | 77.1 K to 73.9 K (-4.22 %) |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 12,188 | 0 | 77,107 | 64.9 K to 77.1 K (+18.77 %) |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | A | 0.85 | 112,500 | 95,625 | 112,500 | |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Option Exercise | M | 0.00 | 3,125 | 0 | 9,375 | |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Sell | S | 0.83 | 834 | 692 | 5,864 | 6.7 K to 5.9 K (-12.45 %) |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Bencich John | CFO | Buy | M | 0.00 | 3,125 | 0 | 6,698 | 3.6 K to 6.7 K (+87.46 %) |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 0.85 | 135,000 | 114,750 | 135,000 | |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 0.85 | 300,000 | 255,000 | 300,000 | |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 9,375 | 0 | 28,125 | |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 6,250 | 0 | 12,500 | |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,688 | 0 | 4,687 | |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,687 | 0 | 0 | |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | S | 0.83 | 12,033 | 9,987 | 124,909 | 136.9 K to 124.9 K (-8.79 %) |
Mar 16 2016 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 25,000 | 0 | 136,942 | 111.9 K to 136.9 K (+22.33 %) |